Dr Amol Patel speaks to ecancer about the trials in low-middle-income countries versus high-income countries and how the standards are applied globally.

He discusses how LMIC’s standards are different in comparison to HICs.

He explores the benefits of exchanging results of trials with other healthcare professionals.